Svea Vaccin and Världsinfektionsfonden announce a research travel grant for young researchers of up to 25,000 SEK for research on a new tuberculosis vaccine.
The research may include the development of new vaccine candidates and adjuvants, markers for vaccine-induced immune responses, preclinical and clinical studies. Indirect costs are not allowed.
The work is expected to take place during 2019. The applicant is supposed to be registered at a Swedish university, at least at masters level.
Deadline 14 December 2018.
The application must be formatted as follows:
- No longer than two (2) pages
- 12 point font
- Single line spacing
- Arial or Times New Roman font
Proposals that do not adhere to these restrictions may be blocked from review.
Include budget and time plan in the proposal.
Submit your proposal to email@example.com. Also submit a CV in the application letter.
Successful applicants will receive funding in December 2018 and are expected to write a 2-page report for Vif that may be used for communication purposes at www.vif.se.
For questions, please write to firstname.lastname@example.org.